DHODH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DHODH monoclonal antibodies for investigating dihydroorotate dehydrogenase (DHODH) protein. DHODH monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dihydroorotate dehydrogenase plays a crucial role in the de novo pyrimidine biosynthesis pathway, catalyzing the conversion of dihydroorotate to orotate. The enzyme is essential for the proliferation of cells, particularly in rapidly dividing tissues, and has been implicated in various diseases, including cancer and autoimmune disorders. Understanding the function and regulation of DHODH is vital for developing targeted therapies and advancing our knowledge of cellular metabolism. DHODH monoclonal antibodies enable researchers to explore protein expression patterns across different tissue types and experimental conditions. Investigating DHODH activity and regulation can provide insights into cellular energy metabolism and disease mechanisms. The high specificity of DHODH monoclonal antibodies from Santa Cruz Biotechnology supports researchers in advancing scientific understanding of cellular processes and disease pathways.